Apeikon raises €1.0M Seed round
1 March 2022· Barcelona, Spain· infrastructure, energy, ai, geospatial, b2b, software_hardware
The funding from the Innovate UK Biomedical Catalyst grant will be used to advance the company's image-guided targeted drug delivery platform for cancer treatment, specifically focusing on brain tumours.
Investors
LeadInnovate UK
About Apeikon
Stage
Pre-Seed
Headquarters
Barcelona, Spain
Founded
2021
Team Size
6–20
Sectors
infrastructureenergyaigeospatialb2bsoftware_hardware
Source: https://www.apeikon.co.uk/news/